Trials / Conditions / Hemolytic Disease of the Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn

4 registered clinical trials studyying Hemolytic Disease of the Fetus and Newborn — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry NCT07194070	Janssen Research & Development, LLC	—
Recruiting	Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anem NCT06984445	Institute of Mother and Child, Warsaw, Poland	—
Recruiting	A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) NCT05912517	Janssen Research & Development, LLC	Phase 3
Completed	A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregna NCT03842189	Janssen Research & Development, LLC	Phase 2